What Neuspera’s 12-month iSNM trial data means for the sacral neuromodulation competitive landscape
Neuspera Medical's 12-month pivotal SNM trial shows 94% responder rates and zero infections. Analysing what this means for the SNM market. Read more.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
How Mitria Medical’s nitinol spacer challenges the edge-to-edge repair model for functional mitral regurgitation
Mitria Medical's Subvalvular Spacer reaches the U.S. under FDA compassionate use. What it means for FMR patients and what clinical evidence still needs to come.
Medical Devices & Diagnostics
FDA clears compact SPRY TMS system: can Soterix Medical disrupt the depression treatment market?
Soterix Medical wins FDA clearance for SPRY TMS in treatment-resistant major depression. What the clearance means for the neuromodulation market. Read the analysis.
Medical Devices & Diagnostics
Can Francis Medical’s Vanquish system reshape minimally invasive prostate cancer treatment?
Francis Medical launches commercial Vanquish procedures for prostate tissue ablation. Explore what this means for minimally invasive prostate cancer treatment.
Medical Devices & Diagnostics
Can preservation-focused implant systems reshape implant dentistry? Nuventus introduces NV.C in the United States
Nuventus launches NV.C Implant System in the United States, highlighting preservation-focused implant design. Discover what this means for clinicians and the market.
Medical Devices & Diagnostics
What Bayer’s MRXperion 510(k) clearance means for high-field MRI workflow and contrast injection systems
FDA clears expanded capabilities for Bayer MRXperion MRI injector supporting scanners up to 7T. Discover what this means for imaging workflows and radiology systems.
Medical Devices & Diagnostics
Can 3D printed medicines reach community pharmacies? Pete Pharma and Atrium24 test a new distribution model
Pete Pharma and Atrium24 partner to expand pharmaceutical 3D printing in independent pharmacies. Explore what this shift means for drug manufacturing.
Medical Devices & Diagnostics
Can CereVasc’s eShunt system change the future of idiopathic intracranial hypertension treatment?
CereVasc’s eShunt system shows three-year outcomes in idiopathic intracranial hypertension. Discover what this means for future brain pressure treatments.
Medical Devices & Diagnostics
Why Airiver Medical’s paclitaxel drug coated balloon could reshape minimally invasive airway treatment
Airiver Medical wins FDA Breakthrough Device status for its pulmonary drug coated balloon. Discover what this means for airway stenosis treatment and clinical trials.
Medical Devices & Diagnostics
Intrinsic Therapeutics introduces Barricaid Narrow Anchor as surgeons seek better reherniation prevention tools
Intrinsic Therapeutics launches the Barricaid Narrow Anchor for lumbar discectomy patients. Explore what the smaller implant could change in spine surgery.